Financial reports
NT 10-K
Notice of late annual filing
28 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
10 Mar 23
10-K/A
2021 FY
Annual report (amended)
10 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
Current reports
8-K
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
11 Mar 24
8-K
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
26 Jan 24
8-K/A
Financial Statements and Exhibits
5 Jan 24
8-K
OptimizeRx Reports Third Quarter 2023 Financial Results
6 Nov 23
8-K
Entry into a Material Definitive Agreement
25 Oct 23
8-K
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
16 Oct 23
8-K
OptimizeRx Reports Second Quarter 2023 Financial Results
14 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
7 Jun 23
8-K
OptimizeRx Reports First Quarter 2023 Financial Results
10 May 23
8-K
Other Events
14 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
31 Aug 21
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Aug 21
S-8
Registration of securities for employees
29 Mar 21
424B5
Prospectus supplement for primary offering
10 Feb 21
424B5
Prospectus supplement for primary offering
8 Feb 21
S-3ASR
Automatic shelf registration
8 Feb 21
S-8
Registration of securities for employees
10 Apr 20
424B5
Prospectus supplement for primary offering
6 Jun 19
424B5
Prospectus supplement for primary offering
4 Jun 19
S-8
Registration of securities for employees
12 Mar 19
Proxies
DEF 14A
Definitive proxy
25 Apr 23
DEF 14A
Definitive proxy
25 Apr 22
DEF 14A
Definitive proxy
8 Jul 21
DEF 14A
Definitive proxy
1 Oct 20
DEF 14A
Definitive proxy
24 Sep 19
DEF 14C
Information statement
17 Jun 13
Other
EFFECT
Notice of effectiveness
12 Dec 18
CORRESP
Correspondence with SEC
10 Dec 18
UPLOAD
Letter from SEC
19 Nov 18
EFFECT
Notice of effectiveness
17 Jul 18
CERT
Certification of approval for exchange listing
22 Jun 18
EFFECT
Notice of effectiveness
8 Jun 18
CORRESP
Correspondence with SEC
6 Jun 18
UPLOAD
Letter from SEC
29 May 18
EFFECT
Notice of effectiveness
17 Jun 16
CORRESP
Correspondence with SEC
14 Jun 16
Ownership
4
Stephen L Silvestro
6 Mar 24
4
Marion Odence-Ford
6 Mar 24
4
Doug Besch
21 Feb 24
4
Edward Stelmakh
21 Feb 24
4
Marion Odence-Ford
21 Feb 24
4
Stephen L Silvestro
21 Feb 24
SC 13G
First Light Asset Management, LLC
14 Feb 24
4
Marion Odence-Ford
13 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
CATHY KLEMA
6 Feb 24